BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 30430700)

  • 1. Characterization of clinical human prostate cancer lesions using 3.0-T sodium MRI registered to Gleason-graded whole-mount histopathology.
    Broeke NC; Peterson J; Lee J; Martin PR; Farag A; Gomez JA; Moussa M; Gaed M; Chin J; Pautler SE; Ward A; Bauman G; Bartha R; Scholl TJ
    J Magn Reson Imaging; 2019 May; 49(5):1409-1419. PubMed ID: 30430700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of T2-Weighted Imaging, DWI, and Dynamic Contrast-Enhanced MRI for Calculation of Prostate Cancer Index Lesion Volume: Correlation With Whole-Mount Pathology.
    Sun C; Chatterjee A; Yousuf A; Antic T; Eggener S; Karczmar GS; Oto A
    AJR Am J Roentgenol; 2019 Feb; 212(2):351-356. PubMed ID: 30540213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI of the Prostate With and Without Endorectal Coil at 3 T: Correlation With Whole-Mount Histopathologic Gleason Score.
    Dhatt R; Choy S; Co SJ; Ischia J; Kozlowski P; Harris AC; Jones EC; Black PC; Goldenberg SL; Chang SD
    AJR Am J Roentgenol; 2020 Jul; 215(1):133-141. PubMed ID: 32160050
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnosis and Grading of Prostate Cancer by Relaxation Maps From Synthetic MRI.
    Cui Y; Han S; Liu M; Wu PY; Zhang W; Zhang J; Li C; Chen M
    J Magn Reson Imaging; 2020 Aug; 52(2):552-564. PubMed ID: 32027071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and stratification of prostate lesions based on comprehensive multiparametric MRI using detailed whole-mount histopathology as a reference standard.
    Starobinets O; Simko JP; Kuchinsky K; Kornak J; Carroll PR; Greene KL; Kurhanewicz J; Noworolski SM
    NMR Biomed; 2017 Dec; 30(12):. PubMed ID: 28961382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IMPROD biparametric MRI in men with a clinical suspicion of prostate cancer (IMPROD Trial): Sensitivity for prostate cancer detection in correlation with whole-mount prostatectomy sections and implications for focal therapy.
    Merisaari H; Jambor I; Ettala O; Boström PJ; Montoya Perez I; Verho J; Kiviniemi A; Syvänen K; Kähkönen E; Eklund L; Pahikkala T; Vainio P; Saunavaara J; Aronen HJ; Taimen P
    J Magn Reson Imaging; 2019 Nov; 50(5):1641-1650. PubMed ID: 30903647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Stratification of Prostate Cancer Using the Combination of Histogram Analysis of Apparent Diffusion Coefficient Across Tumor Diffusion Volume and Clinical Information: A Pilot Study.
    Zhang Z; Xu H; Xue Y; Li J; Ye Q
    J Magn Reson Imaging; 2019 Feb; 49(2):556-564. PubMed ID: 30173421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prebiopsy multiparametric MRI-based risk score for predicting prostate cancer in biopsy-naive men with prostate-specific antigen between 4-10 ng/mL.
    Dwivedi DK; Kumar R; Dwivedi AK; Bora GS; Thulkar S; Sharma S; Gupta SD; Jagannathan NR
    J Magn Reson Imaging; 2018 May; 47(5):1227-1236. PubMed ID: 28872226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraductal carcinoma of the prostate (IDC-P) lowers apparent diffusion coefficient (ADC) values among intermediate risk prostate cancers.
    Currin S; Flood TA; Krishna S; Ansari A; McInnes MDF; Schieda N
    J Magn Reson Imaging; 2019 Jul; 50(1):279-287. PubMed ID: 30585372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Gleason 6 prostate cancer in patients with clinically significant prostate cancer on multiparametric magnetic resonance imaging.
    Chaloupka M; Bischoff R; Pfitzinger P; Lellig E; Ledderose S; Buchner A; Schlenker B; Stief C; Clevert DA; Apfelbeck M
    Clin Hemorheol Microcirc; 2019; 73(1):105-111. PubMed ID: 31561351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transition zone prostate cancer: Logistic regression and machine-learning models of quantitative ADC, shape and texture features are highly accurate for diagnosis.
    Wu M; Krishna S; Thornhill RE; Flood TA; McInnes MDF; Schieda N
    J Magn Reson Imaging; 2019 Sep; 50(3):940-950. PubMed ID: 30701625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of ADC, T2 signal intensity, and a combination of both parameters to assess Gleason score and primary Gleason grades in patients with known prostate cancer.
    Nowak J; Malzahn U; Baur AD; Reichelt U; Franiel T; Hamm B; Durmus T
    Acta Radiol; 2016 Jan; 57(1):107-14. PubMed ID: 25505225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathological Features of MRI-Invisible Regions of Prostate Cancer Lesions.
    van Houdt PJ; Ghobadi G; Schoots IG; Heijmink SWTPJ; de Jong J; van der Poel HG; Pos FJ; Rylander S; Bentzen L; Haustermans K; van der Heide UA
    J Magn Reson Imaging; 2020 Apr; 51(4):1235-1246. PubMed ID: 31588646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing structure of normal and malignant prostate tissue before and after radiation therapy with luminal water fraction and diffusion-weighted MRI.
    Carlin D; Orton MR; Collins D; deSouza NM
    J Magn Reson Imaging; 2019 Aug; 50(2):619-627. PubMed ID: 30589150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stratification of the aggressiveness of prostate cancer using pre-biopsy multiparametric MRI (mpMRI).
    Dwivedi DK; Kumar R; Bora GS; Thulkar S; Sharma S; Gupta SD; Jagannathan NR
    NMR Biomed; 2016 Mar; 29(3):232-8. PubMed ID: 26730884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninferiority of Monoparametric MRI Versus Multiparametric MRI for the Detection of Prostate Cancer: Diagnostic Accuracy of ADC Ratios Based on Advanced "Zoomed" Diffusion-Weighted Imaging.
    Raczeck P; Frenzel F; Woerner T; Graeber S; Bohle RM; Ziegler G; Buecker A; Schneider GK
    Invest Radiol; 2022 Apr; 57(4):233-241. PubMed ID: 34743133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinically insignificant prostate cancer suitable for active surveillance according to Prostate Cancer Research International: Active surveillance criteria: Utility of PI-RADS v2.
    Yim JH; Kim CK; Kim JH
    J Magn Reson Imaging; 2018 Apr; 47(4):1072-1079. PubMed ID: 28901655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADC Metrics From Multiparametric MRI: Histologic Downgrading of Gleason Score 9 or 10 Prostate Cancers Diagnosed at Nontargeted Transrectal Ultrasound-Guided Biopsy.
    Sadoughi N; Krishna S; McInnes MDF; Flood TA; Breau RH; Morash C; Schieda N
    AJR Am J Roentgenol; 2018 Sep; 211(3):W158-W165. PubMed ID: 29995495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.